Dabroś W, Kordowiak A M, Dziga D, Gryboś R
Department of Clinical and Experimental Pathomorphology, Jagiellonian University, Kraków, Poland.
Pol J Pathol. 1998;49(2):67-76.
The relation between bis(maltolato)oxovanadium(IV) (BMOV) influencing the biochemical activity of rat liver Golgi apparatus and the morphology of this organelle was studied in normal and streptozotocin-diabetic rat livers. Ultrastructural examinations revealed marked differences in the morphology of Golgi apparatus in three groups of animals. In the control rats treated only with 0.5% NaCl we did not find any biochemical and morphological changes. Marked changes were found in the rat liver after 1.8 mmol BMOV in 0.5% NaCl (as drinking solution) applied for 7 days, so-called "control" group for vanadium. In this group Golgi apparatus seemed shorter than in the diabetic animals. Finally, the same treatment of rats with previously induced SZ-diabetes, showed relatively small morphological alterations. The ultrastructural observation was compatible with the activity of galactosyltransferase (GalT), the Golgi marker enzyme. In diabetic rats treated with BMOV the activity of this enzyme was almost the same as in controls. Summing up dramatic alterations, previously found in diabetic-untreated rats [22], normalized after orally applied BMOV solution, even after a short time.
在正常和链脲佐菌素诱导的糖尿病大鼠肝脏中,研究了双(麦芽醇)氧钒(IV)(BMOV)对大鼠肝脏高尔基体生化活性的影响及其与该细胞器形态的关系。超微结构检查显示,三组动物的高尔基体形态存在显著差异。在仅用0.5%氯化钠处理的对照大鼠中,未发现任何生化和形态学变化。在以0.5%氯化钠(作为饮用水)给予1.8 mmol BMOV 7天的大鼠肝脏中发现了明显变化,该组为钒的“对照组”。在该组中,高尔基体似乎比糖尿病动物中的更短。最后,对先前诱导的链脲佐菌素糖尿病大鼠进行相同处理,显示出相对较小的形态学改变。超微结构观察结果与高尔基体标记酶半乳糖基转移酶(GalT)的活性相符。在用BMOV处理的糖尿病大鼠中,该酶的活性与对照组几乎相同。综上所述,先前在未治疗的糖尿病大鼠中发现的显著变化,在口服BMOV溶液后即使短时间内也恢复正常。